Cargando…
The impact of hypoxia on B cells in COVID-19
BACKGROUND: Prominent early features of COVID-19 include severe, often clinically silent, hypoxia and a pronounced reduction in B cells, the latter important in defence against SARS-CoV-2. This presentation resembles the phenotype of mice with VHL-deficient B cells, in which Hypoxia-Inducible Factor...
Autores principales: | Kotagiri, Prasanti, Mescia, Federica, Hanson, Aimee L., Turner, Lorinda, Bergamaschi, Laura, Peñalver, Ana, Richoz, Nathan, Moore, Stephen D., Ortmann, Brian M., Dunmore, Benjamin J., Morgan, Michael D., Tuong, Zewen Kelvin, Göttgens, Berthold, Toshner, Mark, Hess, Christoph, Maxwell, Patrick. H., Clatworthy, Menna. R., Nathan, James A., Bradley, John R., Lyons, Paul A., Burrows, Natalie, Smith, Kenneth G.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856886/ https://www.ncbi.nlm.nih.gov/pubmed/35189575 http://dx.doi.org/10.1016/j.ebiom.2022.103878 |
Ejemplares similares
-
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination
por: Kotagiri, Prasanti, et al.
Publicado: (2022) -
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
por: Bergamaschi, Laura, et al.
Publicado: (2021) -
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection
por: Ruffieux, Hélène, et al.
Publicado: (2023) -
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
por: Wang, Jun, et al.
Publicado: (2022) -
Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis
por: Richoz, Nathan, et al.
Publicado: (2022)